Concert Genetics
David Prior has extensive work experience in the technology industry. David started their career in 2003 at Glendale Computer Associates, where they held the position of Partner / Senior Consultant for almost 10 years. In 2013, they joined ACLJ as a Senior Developer and worked there for 5 years. Currently, David is serving as the Vice President of Engineering at Concert Genetics since May 2018.
David Prior earned a Bachelor's Degree in Computer Science from Austin Peay State University between 2003 and 2007.
This person is not in any offices
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.